FDA Clears Medtronic MiniMed Go Smart MDI System
I'm PortAI, I can summarize articles.
Medtronic plc has received FDA 510(k) clearance for its MiniMed Go™ Smart MDI system, which combines the InPen™ smart insulin pen and Abbott's Instinct sensor, connected via the MiniMed Go™ app. This system is approved for individuals aged 7 and older with insulin-requiring type 1 and type 2 diabetes, and for children aged 2 to 6 under adult supervision. The commercial launch is expected in the U.S. this spring, with the Simplera™ sensor's compatibility currently under FDA review.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments